TENET HEALTHCARE CORP
THCTenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How THC's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VB119 | Phase 2 | Membranous Nephropathy | - | - |
Frequently asked questions
What is in TENET HEALTHCARE CORP's drug pipeline?→
CatalystAlert tracks 1 drug candidate in TENET HEALTHCARE CORP's (THC) pipeline across Phase 2. Its lead program is VB119 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is TENET HEALTHCARE CORP's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for TENET HEALTHCARE CORP (THC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track THC biotech catalysts?→
Add THC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TENET HEALTHCARE CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.